questionsmedicales.fr
Acides aminés, peptides et protéines
Protéines
Protéines de liaison à l'ADN
Protéines MutS
Protéines MutS : Questions médicales fréquentes
Termes MeSH sélectionnés :
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Protéines MutS : Questions médicales les plus fréquentes",
"headline": "Protéines MutS : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Protéines MutS : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-03-25",
"dateModified": "2025-03-20",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Protéines MutS"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Protéines de liaison à l'ADN",
"url": "https://questionsmedicales.fr/mesh/D004268",
"about": {
"@type": "MedicalCondition",
"name": "Protéines de liaison à l'ADN",
"code": {
"@type": "MedicalCode",
"code": "D004268",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.260"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Protéine MutS de liaison aux mésappariements de l'ADN",
"alternateName": "MutS DNA Mismatch-Binding Protein",
"url": "https://questionsmedicales.fr/mesh/D051719",
"about": {
"@type": "MedicalCondition",
"name": "Protéine MutS de liaison aux mésappariements de l'ADN",
"code": {
"@type": "MedicalCode",
"code": "D051719",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.260.556.500"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Protéine-3 homologue de MutS",
"alternateName": "MutS Homolog 3 Protein",
"url": "https://questionsmedicales.fr/mesh/D000074081",
"about": {
"@type": "MedicalCondition",
"name": "Protéine-3 homologue de MutS",
"code": {
"@type": "MedicalCode",
"code": "D000074081",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.260.556.875"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Protéines MutS",
"alternateName": "MutS Proteins",
"code": {
"@type": "MedicalCode",
"code": "D000074080",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Taiki Futagami",
"url": "https://questionsmedicales.fr/author/Taiki%20Futagami",
"affiliation": {
"@type": "Organization",
"name": "United Graduate School of Agricultural Sciences, Kagoshima University, Kagoshima 890-0065, Japan; Graduate School of Agriculture, Forestry and Fisheries, Kagoshima University, Kagoshima 890-0065, Japan; Education and Research Center for Fermentation Studies, Faculty of Agriculture, Kagoshima University, Kagoshima 890-0065, Japan. Electronic address: futagami@agri.kagoshima-u.ac.jp."
}
},
{
"@type": "Person",
"name": "Kayu Okutsu",
"url": "https://questionsmedicales.fr/author/Kayu%20Okutsu",
"affiliation": {
"@type": "Organization",
"name": "Graduate School of Agriculture, Forestry and Fisheries, Kagoshima University, Kagoshima 890-0065, Japan; Education and Research Center for Fermentation Studies, Faculty of Agriculture, Kagoshima University, Kagoshima 890-0065, Japan."
}
},
{
"@type": "Person",
"name": "Yumiko Yoshizaki",
"url": "https://questionsmedicales.fr/author/Yumiko%20Yoshizaki",
"affiliation": {
"@type": "Organization",
"name": "United Graduate School of Agricultural Sciences, Kagoshima University, Kagoshima 890-0065, Japan; Graduate School of Agriculture, Forestry and Fisheries, Kagoshima University, Kagoshima 890-0065, Japan; Education and Research Center for Fermentation Studies, Faculty of Agriculture, Kagoshima University, Kagoshima 890-0065, Japan."
}
},
{
"@type": "Person",
"name": "Kazunori Takamine",
"url": "https://questionsmedicales.fr/author/Kazunori%20Takamine",
"affiliation": {
"@type": "Organization",
"name": "United Graduate School of Agricultural Sciences, Kagoshima University, Kagoshima 890-0065, Japan; Graduate School of Agriculture, Forestry and Fisheries, Kagoshima University, Kagoshima 890-0065, Japan; Education and Research Center for Fermentation Studies, Faculty of Agriculture, Kagoshima University, Kagoshima 890-0065, Japan."
}
},
{
"@type": "Person",
"name": "Hisanori Tamaki",
"url": "https://questionsmedicales.fr/author/Hisanori%20Tamaki",
"affiliation": {
"@type": "Organization",
"name": "United Graduate School of Agricultural Sciences, Kagoshima University, Kagoshima 890-0065, Japan; Graduate School of Agriculture, Forestry and Fisheries, Kagoshima University, Kagoshima 890-0065, Japan; Education and Research Center for Fermentation Studies, Faculty of Agriculture, Kagoshima University, Kagoshima 890-0065, Japan."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Sleep Dysfunction in Movement Disorders: a Window to the Disease Biology.",
"datePublished": "2022-07-22",
"url": "https://questionsmedicales.fr/article/35867306",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s11910-022-01220-8"
}
},
{
"@type": "ScholarlyArticle",
"name": "Movement disorders in children: recognition and management in the emergency department.",
"datePublished": "2022-12-01",
"url": "https://questionsmedicales.fr/article/36378853",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": null
}
},
{
"@type": "ScholarlyArticle",
"name": "Perception-Action Integration Is Altered in Functional Movement Disorders.",
"datePublished": "2023-06-14",
"url": "https://questionsmedicales.fr/article/37315159",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1002/mds.29458"
}
},
{
"@type": "ScholarlyArticle",
"name": "Movement Disorders in Patients With Genetic Developmental and Epileptic Encephalopathies.",
"datePublished": "2023-09-25",
"url": "https://questionsmedicales.fr/article/37748886",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1212/WNL.0000000000207808"
}
},
{
"@type": "ScholarlyArticle",
"name": "Movement disorders in Indochina: Resource challenges and future solutions.",
"datePublished": "2023-06-12",
"url": "https://questionsmedicales.fr/article/37306791",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s00702-023-02662-1"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Acides aminés, peptides et protéines",
"item": "https://questionsmedicales.fr/mesh/D000602"
},
{
"@type": "ListItem",
"position": 3,
"name": "Protéines",
"item": "https://questionsmedicales.fr/mesh/D011506"
},
{
"@type": "ListItem",
"position": 4,
"name": "Protéines de liaison à l'ADN",
"item": "https://questionsmedicales.fr/mesh/D004268"
},
{
"@type": "ListItem",
"position": 5,
"name": "Protéines MutS",
"item": "https://questionsmedicales.fr/mesh/D000074080"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Protéines MutS - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Protéines MutS",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-12",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Protéines MutS",
"description": "Comment diagnostiquer une déficience en protéines MutS ?\nQuels tests sont utilisés pour évaluer l'activité des protéines MutS ?\nLes biopsies peuvent-elles aider au diagnostic ?\nQuels symptômes peuvent indiquer un problème avec MutS ?\nY a-t-il des marqueurs biologiques associés à MutS ?",
"url": "https://questionsmedicales.fr/mesh/D000074080?mesh_terms=Movement+Disorders&page=3#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Protéines MutS",
"description": "Quels sont les symptômes d'une mutation de MutS ?\nLes symptômes sont-ils toujours présents ?\nComment les symptômes varient-ils selon les individus ?\nLes symptômes peuvent-ils apparaître tardivement ?\nY a-t-il des symptômes associés à d'autres maladies ?",
"url": "https://questionsmedicales.fr/mesh/D000074080?mesh_terms=Movement+Disorders&page=3#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Protéines MutS",
"description": "Comment prévenir les cancers liés à MutS ?\nLes changements de mode de vie aident-ils ?\nLes tests génétiques sont-ils recommandés ?\nY a-t-il des recommandations alimentaires ?\nLes vaccinations peuvent-elles aider ?",
"url": "https://questionsmedicales.fr/mesh/D000074080?mesh_terms=Movement+Disorders&page=3#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Protéines MutS",
"description": "Quels traitements sont disponibles pour les cancers liés à MutS ?\nLa thérapie génique est-elle une option ?\nComment la surveillance est-elle effectuée ?\nY a-t-il des traitements préventifs ?\nLes traitements ciblés sont-ils efficaces ?",
"url": "https://questionsmedicales.fr/mesh/D000074080?mesh_terms=Movement+Disorders&page=3#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Protéines MutS",
"description": "Quelles complications peuvent survenir avec MutS ?\nLes complications sont-elles réversibles ?\nComment les complications affectent-elles la qualité de vie ?\nY a-t-il des complications psychologiques ?\nLes complications peuvent-elles être prévenues ?",
"url": "https://questionsmedicales.fr/mesh/D000074080?mesh_terms=Movement+Disorders&page=3#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Protéines MutS",
"description": "Quels sont les principaux facteurs de risque liés à MutS ?\nL'âge est-il un facteur de risque ?\nLe sexe influence-t-il le risque ?\nLes habitudes de vie jouent-elles un rôle ?\nY a-t-il des facteurs environnementaux à considérer ?",
"url": "https://questionsmedicales.fr/mesh/D000074080?mesh_terms=Movement+Disorders&page=3#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une déficience en protéines MutS ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests génétiques peuvent identifier des mutations dans les gènes codant pour MutS."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour évaluer l'activité des protéines MutS ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests de réparation de l'ADN in vitro peuvent mesurer l'activité des protéines MutS."
}
},
{
"@type": "Question",
"name": "Les biopsies peuvent-elles aider au diagnostic ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des biopsies tumorales peuvent révéler des anomalies dans les protéines MutS."
}
},
{
"@type": "Question",
"name": "Quels symptômes peuvent indiquer un problème avec MutS ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des symptômes de cancer héréditaire peuvent suggérer une déficience en MutS."
}
},
{
"@type": "Question",
"name": "Y a-t-il des marqueurs biologiques associés à MutS ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des niveaux anormaux de certains biomarqueurs peuvent indiquer une dysfonction de MutS."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes d'une mutation de MutS ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les mutations peuvent entraîner des cancers, notamment le cancer colorectal héréditaire."
}
},
{
"@type": "Question",
"name": "Les symptômes sont-ils toujours présents ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, certains individus porteurs de mutations peuvent ne pas présenter de symptômes visibles."
}
},
{
"@type": "Question",
"name": "Comment les symptômes varient-ils selon les individus ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes peuvent varier en fonction de l'âge et de l'historique familial."
}
},
{
"@type": "Question",
"name": "Les symptômes peuvent-ils apparaître tardivement ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certains cancers liés à MutS peuvent se développer plus tard dans la vie."
}
},
{
"@type": "Question",
"name": "Y a-t-il des symptômes associés à d'autres maladies ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des symptômes similaires peuvent être observés dans d'autres syndromes de cancer héréditaire."
}
},
{
"@type": "Question",
"name": "Comment prévenir les cancers liés à MutS ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "La prévention inclut des dépistages réguliers et des conseils génétiques pour les familles."
}
},
{
"@type": "Question",
"name": "Les changements de mode de vie aident-ils ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un mode de vie sain peut réduire le risque de cancer, même avec des mutations."
}
},
{
"@type": "Question",
"name": "Les tests génétiques sont-ils recommandés ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les tests génétiques peuvent aider à identifier les individus à risque élevé."
}
},
{
"@type": "Question",
"name": "Y a-t-il des recommandations alimentaires ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une alimentation riche en fibres et en antioxydants est conseillée pour la prévention."
}
},
{
"@type": "Question",
"name": "Les vaccinations peuvent-elles aider ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines vaccinations, comme contre le HPV, peuvent réduire le risque de cancers associés."
}
},
{
"@type": "Question",
"name": "Quels traitements sont disponibles pour les cancers liés à MutS ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements incluent la chirurgie, la chimiothérapie et l'immunothérapie."
}
},
{
"@type": "Question",
"name": "La thérapie génique est-elle une option ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "La thérapie génique est en recherche, mais pas encore une option standard pour MutS."
}
},
{
"@type": "Question",
"name": "Comment la surveillance est-elle effectuée ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une surveillance régulière par des examens endoscopiques est recommandée pour les porteurs."
}
},
{
"@type": "Question",
"name": "Y a-t-il des traitements préventifs ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des interventions chirurgicales prophylactiques peuvent être envisagées pour réduire le risque."
}
},
{
"@type": "Question",
"name": "Les traitements ciblés sont-ils efficaces ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des traitements ciblés sont en développement et montrent des résultats prometteurs."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec MutS ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent un risque accru de divers cancers et des syndromes associés."
}
},
{
"@type": "Question",
"name": "Les complications sont-elles réversibles ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines complications peuvent être gérées, mais d'autres peuvent être permanentes."
}
},
{
"@type": "Question",
"name": "Comment les complications affectent-elles la qualité de vie ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications peuvent réduire la qualité de vie en raison des traitements et des symptômes."
}
},
{
"@type": "Question",
"name": "Y a-t-il des complications psychologiques ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le diagnostic de mutations MutS peut entraîner de l'anxiété et du stress."
}
},
{
"@type": "Question",
"name": "Les complications peuvent-elles être prévenues ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une surveillance régulière et des interventions précoces peuvent aider à prévenir certaines complications."
}
},
{
"@type": "Question",
"name": "Quels sont les principaux facteurs de risque liés à MutS ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les antécédents familiaux de cancer et les mutations génétiques sont des facteurs clés."
}
},
{
"@type": "Question",
"name": "L'âge est-il un facteur de risque ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le risque de cancer augmente avec l'âge, surtout chez les porteurs de mutations MutS."
}
},
{
"@type": "Question",
"name": "Le sexe influence-t-il le risque ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines mutations peuvent avoir un impact différent selon le sexe, affectant le risque de cancer."
}
},
{
"@type": "Question",
"name": "Les habitudes de vie jouent-elles un rôle ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des habitudes de vie malsaines peuvent augmenter le risque de cancer chez les porteurs."
}
},
{
"@type": "Question",
"name": "Y a-t-il des facteurs environnementaux à considérer ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'exposition à certains agents cancérigènes peut augmenter le risque chez les porteurs de MutS."
}
}
]
}
]
}
To comprehensively summarize the sleep pathologies associated with movement disorders, focusing on neurodegenerative diseases....
Mounting evidence has further implicated both sleep and circadian disruption in the pathophysiology of many movement disorders. In particular, recent data illuminate the mechanisms by which poor sleep...
The differential diagnosis for pediatric patients presenting to the emergency department with movement-based neurological complaints is wide. Clinicians must ensure these children receive an appropria...
Although functional neurological movement disorders (FMD) are characterized by motor symptoms, sensory processing has also been shown to be disturbed. However, how the integration of perception and mo...
The aim was to investigate perception-action integration processes on a behavioral and neurophysiological level in patients with FMD....
A total of 21 patients and 21 controls were investigated with a TEC-related task, including concomitant electroencephalogram (EEG) recording. We focused on EEG correlates established to reflect percep...
Behaviorally, patients revealed stronger binding between perception and action, as evidenced by difficulties in reconfiguring previously established stimulus-response associations. Such hyperbinding w...
Our study shows that FMD is characterized by altered integration of sensory information with motor processes. Relations between clinical severity and both behavioral performance and neurophysiological...
Movement disorders (MDs) are underrecognized in the developmental and epileptic encephalopathies (DEEs). There are now more than 800 genes implicated in causing the DEEs; relatively few of these rare ...
We classified the type of MDs associated with specific genetic DEEs in a large international cohort of patients and analyzed whether specific patterns of MDs reflected the underlying biological dysfun...
Our cohort comprised 77 patients with a genetic DEE with a median age of 9 (range 1-38) years. Stereotypies (37/77, 48%) and dystonia (34/77, 44%) were the most frequent MDs, followed by chorea (18/77...
MDs are often underrecognized in patients with genetic DEEs, but recognition is critical for the management of these complex neurologic diseases. Distinguishing MDs from epileptic seizures is importan...
Movement disorders are a major cause of disability worldwide and their increasing prevalence predicts a substantial future burden of care. Impactful patient care requires availability of, and accessib...
Numerous lines of research indicate that our social brain involves a network of cortical and subcortical brain regions that are responsible for sensing and controlling body movements. However, it rema...
Our clinical series comprises 124 patients with movement disorders (MDs) and/or ataxia with cerebellar atrophy (CA), many of them showing signs of neurodegeneration with brain iron accumulation (NBIA)...
The last decade has seen development of numerous novel antipsychotic drugs with unique mechanisms including long-acting formulations for clinical use. A comparative assessment of these new drugs with ...
Medline was searched from January 2010 to February 2022 for primary research articles and review articles in English using the search terms "extrapyramidal" and "tardive" with individual drug names of...
We identified articles describing the risk of DIMD with 6 novel antipsychotics, 4 novel formulations, and 3 experimental antipsychotics. Both short- and long-term data generally showed comparable to l...
Several novel antipsychotics, particularly lumateperone and pimavanserin, show promise in being able to treat psychosis while reducing the risk of DIMD. Long-acting paliperidone may reduce risk of DIM...
Movement disorder (MD) is an important manifestation of neurologic Wilson disease (NWD), but there is a paucity of information on dopaminergic pathways. We evaluate dopamine and its receptors in patie...
Genetics are fundamental to understanding the pathophysiology of neurological disease, including movement disorders. Genetic testing in clinical practice has changed dramatically over the last few dec...